Cargando…
Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Actinic keratosis (AK) is a chronic skin condition that may progress to cutaneous squamous cell carcinoma. We conducted a systematic review of efficacy and safety for key treatments for AK of the face and scalp, including the novel 5-day tirbanibulin 1% ointment. MEDLINE, PubMed, Embase, Cochrane Li...
Autores principales: | Heppt, Markus V., Dykukha, Igor, Graziadio, Sara, Salido-Vallejo, Rafael, Chapman-Rounds, Matt, Edwards, Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952421/ https://www.ncbi.nlm.nih.gov/pubmed/35329979 http://dx.doi.org/10.3390/jcm11061654 |
Ejemplares similares
-
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
por: Dymond, Amy, et al.
Publicado: (2023) -
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
por: Schlesinger, Todd, et al.
Publicado: (2022) -
Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study
por: Kirchberger, Michael Constantin, et al.
Publicado: (2023) -
A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe
por: Vegter, Stefan, et al.
Publicado: (2014) -
Management and clinical practice of multiple face and scalp actinic keratosis in France
por: Savary, Jacques, et al.
Publicado: (2019)